Spexis
Pre-clinicalA Swiss biopharmaceutical company developing novel antibiotics and oncology therapies targeting difficult-to-treat infections and cancers.
Founded
2014
Focus
BiologicsSmall Molecules
About
A Swiss biopharmaceutical company developing novel antibiotics and oncology therapies targeting difficult-to-treat infections and cancers.
Funding History
2Total raised: $120M
Series C$75MUndisclosedSep 15, 2021
Series B$45MNew Enterprise AssociatesMay 15, 2018
Company Info
TypePrivate
Founded2014
LocationAllschwil, Switzerland
StagePre-clinical
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile